title: Peritonectomy procedures.
abstract: Treatment of peritoneal surface malignancy requires a combined approach that uses peritonectomy procedures and perioperative intraperitoneal chemotherapy. In addition, knowledgeable patient selection is mandatory. This article illustrates the visceral and parietal peritonectomy procedures that one must use in an attempt to resect all visible evidence of disease. Complete cytoreduction is essential for treatment of peritoneal surface malignancy to result in long-term survival. Several different procedures are required in a single surgical event that may require 8-12 hours. Their use depends on the distribution and extent of invasion of the malignancy disseminated within the peritoneal space.
authors.affiliation: Program in Peritoneal Surface Malignancy, Washington Cancer Institute, 100 Irving St., NW, Suite CG-185, Washington, DC 20010, USA. Paul.Sugarbaker@medstar.net
authors.forename: Paul H
authors.initials: PH
authors.lastname: Sugarbaker
mesh_terms: D000714:Anastomosis, Surgical; D013505:Digestive System Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D007813:Laparotomy / Q000009:adverse effects / Q000379:methods; D008297:Male; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D010534:Peritoneal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D010537:Peritoneum / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology; D011379:Prognosis; D019651:Plastic Surgery Procedures / Q000379:methods; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States